LeMaitre Vascular, Inc. (LMAT) Q4 2015 Earnings Results

Lemaitre Vascular (LMAT) Beats on EPS, Stock Up 4.47%

Lemaitre Vascular's earnings report shows a strong performance in EPS, exceeding expectations significantly. The stock reacted positively, rising 4.47%, likely driven by investor confidence in the company's ability to manage costs and enhance profitability. However, the lack of revenue figures leaves some uncertainty about overall performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.13	N/A	+44.44%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a positive outlook regarding their EPS results. They emphasized their commitment to growth and innovation in the vascular market.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing efforts to enhance product offerings and market reach.

Lemaitre Vascular (LMAT) Beats on EPS, Stock Up 4.47%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular (LMAT) Beats on EPS, Stock Up 4.47%

Key numbers

Management commentary